CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by equities researchers at Truist Financial from $100.00 to $120.00 in a report issued on Wednesday,Benzinga reports.

We recently compiled a list of the 10 Best Bank Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...

Equitable (NYSE:EQH – Get Free Report) had its price target hoisted by research analysts at Truist Financial from $52.00 to ...

Truist Financial Corporation ( NYSE: TFC) UBS Financial Services Conference February 11, 2025 1:00 PM ET Buddy, as I say, no rest for the weary. But obviously my energy levels are back up, because we ...

WSFS makes a move into Bucks County as part of a broader plan to fill in geographic gaps in the bank's wealth management ...

Wells Fargo analyst Mike Mayo maintained a Buy rating on Truist Financial (TFC – Research Report) on February 5 and set a price target of ...

We recently compiled a list of the 10 Best Local Bank Stocks to Buy. In this article, we are going to take a look at where ...

Shares of Truist Financial Corp. TFC advanced 1.01% to $48.15 Thursday, on what proved to be an all-around mixed trading ...

Support from the Truist Charitable Fund will bolster programming at the Jay Hurt Hub for Innovation & Entrepreneurship at ...